|
QIMR Berghofer scientists say the discovery of new cellular immunotherapy targets for a deadly type of head and neck cancer, caused by human papillomavirus (HPV), could lead to better survival rates. The type of head and neck cancer, known as oropharyngeal cancer, can affect the base of the tongue, the tonsils, soft palate and the walls of the pharynx. HPV is detected as the cause of almost 50% of oropharyngeal cancers in Australia.
|